CHMP2B Gene Amyotrophic lateral sclerosis type 17 Genetic Test
Welcome to DNA Labs UAE, where we offer the CHMP2B Gene Amyotrophic lateral sclerosis type 17 Genetic Test. This test is used to analyze the CHMP2B gene and identify any mutations or variations associated with ALS type 17.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Prior to undergoing the CHMP2B Gene Amyotrophic lateral sclerosis type 17 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with CHMP2B Gene Amyotrophic lateral sclerosis type 17.
Test Details
The CHMP2B gene is associated with a rare form of amyotrophic lateral sclerosis (ALS) known as ALS type 17. This type of ALS is characterized by progressive muscle weakness and wasting, leading to difficulty with movement, speaking, and breathing.
NGS (next-generation sequencing) genetic testing is utilized to analyze the CHMP2B gene and identify any mutations or variations that may be associated with ALS type 17. This type of testing can aid in the diagnosis of the condition and provide information for genetic counseling and symptom management.
It is important to note that genetic testing for ALS type 17 is not routinely performed. It is typically recommended for individuals with a strong family history of the condition or those who have already been diagnosed with ALS and are not showing typical symptoms. Additionally, genetic testing alone cannot confirm a diagnosis of ALS and should be used in conjunction with other diagnostic tools, such as clinical evaluation and electromyography (EMG) testing.
Test Name | CHMP2B Gene Amyotrophic lateral sclerosis type 17 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CHMP2B Gene Amyotrophic lateral sclerosis type 17 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CHMP2B Gene Amyotrophic lateral sclerosis type 17 |
Test Details | The CHMP2B gene is associated with a rare form of amyotrophic lateral sclerosis (ALS) known as ALS type 17. This type of ALS is characterized by progressive muscle weakness and wasting, leading to difficulty with movement, speaking, and breathing. NGS (next-generation sequencing) genetic testing can be used to analyze the CHMP2B gene and identify any mutations or variations that may be associated with ALS type 17. This type of testing can help diagnose the condition and provide information for genetic counseling and management of symptoms. It is important to note that genetic testing for ALS type 17 is not routinely performed and is typically only recommended for individuals with a strong family history of the condition or those who have already been diagnosed with ALS and are not showing typical symptoms. Additionally, genetic testing alone cannot confirm a diagnosis of ALS and should be used in conjunction with other diagnostic tools, such as clinical evaluation and electromyography (EMG) testing. |